Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

In July 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Antimicrobial Resistance and Infection Control. The title of the study is "High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases". The analysis underscores the critical threat posed by carbapenem-resistant Enterobacteriaceae (CRE) bloodstream infections (BSIs) in neutropenic pediatric hematology patients.
Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study 

Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study 

In November 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Infectious Diseases. The title of the study is "Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study". This comprehensive study sheds light on the significant burden of Acinetobacter spp. BSI in hematological patients, emphasizing the complexity of treating these infections in a population at high risk of adverse outcomes.